Evidence map›Paper›PMID 24724042›Full record

ArticleJournal of Alzheimer's disease & Parkinsonism2013

A Comparative White Matter Study with Parkinson's disease, Parkinson's Disease with Dementia and Alzheimer's Disease.

Rodrigo D Perea, Rebecca C Rada, Jessica Wilson, Eric D Vidoni1, Jill K Morris, Kelly E Lyons, Rajesh Pahwa, Jeffrey M Burns, Robyn A Honea

Open access · hybridAbstract read
In one paragraph

Article in Journal of Alzheimer's disease & Parkinsonism, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Neuroimaging in Dementia.Seminars in neurology · 2017
    Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Rodrigo D PereaDepartment of Neurology, University of Kansas School of Medicine, Kansas City, KS, USA ; Alzheimer's Research Disease Center, University of Kansas School of Medicine, Kansas City, KS, USA ; Bioengineering Program, Department of Engineering, University of Kansas, Lawrence, KS, USA.
Rebecca C RadaAlzheimer's Research Disease Center, University of Kansas School of Medicine, Kansas City, KS, USA.
Jessica WilsonDepartment of Psychology, University of Kansas, Lawrence, KS, USA.
Eric D Vidoni1Alzheimer's Research Disease Center, University of Kansas School of Medicine, Kansas City, KS, USA.
Jill K MorrisDepartment of Neurology, University of Kansas School of Medicine, Kansas City, KS, USA ; Alzheimer's Research Disease Center, University of Kansas School of Medicine, Kansas City, KS, USA.
Kelly E LyonsDepartment of Neurology, University of Kansas School of Medicine, Kansas City, KS, USA.
Rajesh PahwaDepartment of Neurology, University of Kansas School of Medicine, Kansas City, KS, USA.
Jeffrey M BurnsDepartment of Neurology, University of Kansas School of Medicine, Kansas City, KS, USA ; Alzheimer's Research Disease Center, University of Kansas School of Medicine, Kansas City, KS, USA.
Robyn A HoneaDepartment of Neurology, University of Kansas School of Medicine, Kansas City, KS, USA ; Alzheimer's Research Disease Center, University of Kansas School of Medicine, Kansas City, KS, USA ; Bioengineering Program, Department of Engineering, University of Kansas, Lawrence, KS, USA.
University of Kansas · US

Funding

UC Davis Alzheimer's Disease Core CenterP30AG010129 · NIA · UNIVERSITY OF CALIFORNIA DAVIS · PI DECARLI, CHARLES · 1991 to 2020
$28.3M
University of Kansas Alzheimer's Disease Core CentersP30AG035982 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BURNS, JEFFREY MURRAY · 2011 to 2020
$16.6M
WRITING AND WT LOSS MAINTENANCEM01RR023940 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BURNS, JEFFREY MURRAY · 2007 to 2009
$6.6M
HEARTLAND INSTITUTE FOR CLINICAL AND TRANSLATIONAL RESEARCHUL1RR033179 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BAROHN, RICHARD J. · 2011 to 2011
$3.2M
Heartland Institute for Clinical and Translational ResearchKL2TR000119 · NCATS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BAROHN, RICHARD J. · 2012 to 2015
$2.5M
Aerobic Fitness in Slowing the Progression of Alzheimer's DiseaseR01AG033673 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BURNS, JEFFREY MURRAY · 2010 to 2014
$1.7M
Dose-Response Study of Exercise in Older AdultsR01AG034614 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BURNS, JEFFREY MURRAY · 2009 to 2011
$772k
The Role of Genetic Variation in Alzheimer's DiseaseK01AG035042 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI HONEA, ROBYN A · 2011 to 2015
$626k
"MR Morphometrics and Cognitive Decline Rate in Large-Scale Aging Studies"K01AG030514 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CARMICHAEL, OWEN T. · 2008 to 2012
$495k
NCATS NIH HHS KL2 TR000119NCRR NIH HHS M01 RR023940NCRR NIH HHS UL1 RR033179NIA NIH HHS K01 AG030514NIA NIH HHS K01 AG035042NIA NIH HHS P30 AG010129NIA NIH HHS P30 AG035982NIA NIH HHS R01 AG033673NIA NIH HHS R01 AG034614
6 · The paper itself

Abstract

Alzheimer's disease (AD) and Parkinson's disease (PD) are among the most common neurodegenerative disorders affecting older populations. AD is characterized by impaired memory and cognitive decline while the primary symptoms of PD include resting tremor, bradykinesia and rigidity. In PD, mild cognitive changes are frequently present, which could progress to dementia (PD dementia (PDD)). PDD and AD dementias are different in pathology although the difference in microstructural changes remains unknown. To further understand these diseases, it is essential to understand the distinct mechanism of their microstructural changes. We used diffusion tensor imaging (DTI) to investigate white matter tract differences between early stage individuals with AD (n=14), PD (n=12), PDD (n=9), and healthy non-demented controls (CON) (n=13). We used whole brain tract based spatial statistics (TBSS) and a region of interest (ROI) analysis focused on the substantia nigra (SN). We found that individuals with PDD had more widespread white matter degeneration compared to PD, AD, and CON. Individuals with AD had few regional abnormalities in the anterior and posterior projections of the corpus callosum while PD and CON did not appear to have significant white matter degeneration when compared to other groups. ROI analyses showed that PDD had the highest diffusivity in the SN and were significantly different from CON. There were no significant ROI differences between CON, PD, or AD. In conclusion, global white matter microstructural deterioration is evident in individuals with PDD, and DTI may provide a means with which to tease out pathological differences between AD and PD dementias.

Indexed as

CingulumCorpus callosumCorticospinal tractDementiaNeurodegenerative disorders

Identifiers

PMID24724042
PMCPMC3979316
OpenAlexW2100686676

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.